| |
Current Guest Instructors & Lecturers (2010)
Guest Lecturers at Stony Brook University & Stony Brook
Manhattan
- Gretchen Argast, Ph.D., Senior Research Scientist, Cancer Biology, OSI Pharmaceuticals, Inc.
- Michael Bielski, J.D., Assistant Director, Science & Technology Commercialization, Center for Biotechnology
- Mark Citron, TyRx Pharmaceuticals
- Ron Cohen, MD, President and CEO, Acorda Therapeutics
- Anil Dhundale, Ph.D., Executive Director, Long Island High Technology Incubator
- John A. Hill, Business Facilitator, John A. Hill & Associates, Inc
- Coleen Johnson, MS, Reno and Associates
- Sharon Klugewicz, Sr. Vice President, Global Quality Operations, Pall Life Sciences
- Bill Liggan, Director, Human Resources, ICON Central Laboratories
- Walter Mardis, SWG Consulting
- Alan H. Morison, JD, Partner, Cohen Pontani Lieberman & Pavane LLP
- Glen Park, Senior Director, Target Health, Inc.
- Raghuram Selvaraju, Ph.D., Senior Vice President, Head of Healthcare Research, Hapoalim Securities
- Geoffrey W. Smith, Co-Founder and Managing Partner, Ascent Biomedical Ventures
- Chris Szustkiewicz, MBA, PhD, ABCC, President, CK Regulatory & Compliance Associates, Inc.
- Natalya Valiero, Senior Consultant, MDI Consultants, Inc .
Distinguished Past Guest Instructors & Lecturers
- Magdy Abdel-Malik, Ph.D., President, Quaestio Global Partners LLC
- Jeff Aibel, IMS Health
- Jason Alter, Ph.D., Director of Marketing, Aureon Laboratories
- Safi Bahcall, Ph.D., CEO, Synta Pharmaceutical
- Karim Berrada, Ph.D., Director, Drug Discovery Group, inGenious Targeting Laboratory, Inc.
- Michael Boisclair, Ph.D., Director, Leads Discovery, OSI Pharmaceuticals, Inc.
- Elizabeth Buck, Ph.D., Senior Research Scientist, Department of Translational Research, OSI Pharmaceuticals, Inc.
- Brian Buxton, Principal, Easton Associate
- Edward Caffrey, Former President, Icon Clinical Laboratories
- Alain Cappeluti, Vice President, Financial Operations, CoGeneSy
- Mark Carvlin, Partner, SWGC Life Science
- Joseph Ceccoli, Former Chief Operating Officer, The Collaborative Group, Ltd
- Lee Chen, Director of Marketing, Vitatex, inc.
- Tim Cooke, Ph.D., MBA, CEO, Mojave Therapeutics
- Yogita Desai, Ph.D., Assistant Director of Chemical Manufacturing Control, Forest Laboratories, Inc.
- Javan Esfandiari, Ph.D., Vice President, Research and Development, Chembio Diagnostic Systems, Inc.
- Paul Esatto, Partner, Scully Scott Murphy & Presser PC
- Christopher Fenimore, Manager of Finance, Regeneron Pharmaceuticals, Inc.
- Andrew Garton, Ph.D., Senior Research Investigator, OSI Pharmaceuticals, Inc.
- Allen Goldberg, Managing Partner, The Channel Group
- Ron Guido, Vice-President, Regulatory Affairs. LifeCycle Pharma Inc
- Michael Hadjiagyrou, Ph.D., Associate Professor, Department of Biomedical Engineering, Stony Brook University
- John Haley, Ph.D., Senior Director, Molecular Biology, OSI Pharmaceuticals, Inc.
- James Hayward, Former CEO of the Collaborative Group and a founding member of NYBA
- Imran Haque, M.B.A., Director, Business Technology, Pfizer Inc
- Paul Harney, Principal, Swiftwater Group
- Qun-Sheng Ji, Senior Research Investigator of Cancer Biology, OSI Pharmaceuticals, Inc.
- Sandra P. Kim, Ph.D., Patent Department, Pfizer Inc
- Jon Klein, Vice President, AGI Dermatics
- Sharon Klugewicz, Sr. Vice President, Global Quality Operations, Pall Life Sciences
- King Lee, Ph.D., R.A.C., Vice President of Clinical & Regulatory Affairs, Cornerstone Pharmaceuticals
- Gabe Leung, Vice President Commercial Operations, OSI Pharmaceuticals, Inc.
- Peter Ludwig, MS, JD, LLM, Patent Attorney, Partner, Darby and Darb
- Alan McEmber, RAC, Director, Worldwide Regulatory Strategy, Pfizer Inc
- Jules Mitchel, MBA, Ph.D., President, Target Health, Inc.
- Kevin Murphy, Ph.D., Clinical Director of Psychiatry, Pfizer Inc
- Glenn Neuman, New World Regulatory Solutions
- Srinivas Pentyala, Ph.D., Associate Professor & Director of Translational Research, Department of Anesthesiology, Stony Brook University
- Sue Poirier, Pfizer Inc
- Fred Price, Former CEO, BioMarin Pharmaceutical
- Dennis Purcell, Senior Managing Director, Perseus Soros Biopharmaceutical Fun
- Bob Rodriguez, BSc, MBA, CEO and Executive Vice-President of Business Development, Cornerstone Pharmaceuticals
- Barbara Sawitsky, MBA, CLP, Director, Patents and Licensing/Business Development, NY Blood Center and Lindsley F. Kimball Research Institute
- Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative
- Bob Schaffer, JD, Patent Attorney, Partner, Darby and Darb
- Nelson Scharadin, MS, Founder, BioNano Systems, Inc.
- Salam Shabaan, Ph.D., OSI Pharmaceuticals, Inc.
- Paul Sheiffele, Director, Business Development, inGenious Targeting Laboratory, Inc.
- A. Laurie Shroyer, Ph.D., M.S., Professor of Preventive Medicine, Division of Evaluative Sciences, Stony Brook University Medical Center
- Larry Siebert, President, Chembio Diagnostic Systems, Inc.
- Ken Sonnenfeld, Ph.D., Esq., Partner, King & Spalding LLP
- Les Stutzman, Chembio Diagnostic Systems, Inc.
- Dave Sudolsky, MBA, Principal of Sudco Consulting, former president and CEO of Arizeke Pharmaceuticals
- Robert Sullivan, JD, Patent Attorney, Partner, Darby and Darb
- Harri Taranto, Managing Director, Symphony Capital LLC
- Natalya Valiero, Senior Consultant, MDI Consultants, Inc
- Darshan Wariabharaj, Manager, Regulatory Affairs, OSI Pharmaceuticals, Inc.
- Yongzhi (Mimi) Yang, Associate, Scully Scott Murphy & Presser PC
- Xiaochun Zhu, Ph.D., Partner, Scully Scott Murphy & Presser PC
back to top
|
|
